Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Penumbra- Inc. (PEN)

0 (0%)

Open:

Pre. Close:

High:

Low:

Volume:

Market Cap:

0M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

128.925 - 129.42

129.42 - 129.916

Low:

122.285 - 122.872

122.872 - 123.459

Close:

127.334 - 128.251

128.251 - 129.169

Technical analysis  (as of: 2018-08-16 4:30:41 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 161.88     One year: 176.31

Support:

Support1: 118.60    Support2: 98.68

Resistance:

Resistance1: 138.59    Resistance2: 150.95

Pivot:

135.09

Moving Averages:

MA(5): 124.14     MA(20): 136.72

MA(100): 140.06     MA(250): 114.99

MACD:

MACD(12,26): -5.08     Signal(12,26,9): -3.57

%K %D:

%K(14,3): 18.06     %D(3): 12.07

RSI:

RSI(14): 40.47

52-Week:

High:   Low:   Change(%): 54.3

Average Vol(K):

3-Month: 39358  10-Days 55049

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PEN has closed above bottom band by 33.9%. Bollinger Bands are 110.1% wider than normal. The large width of the bands suggest high volatility as compared to PEN's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-08-07T20:59:04-04:00
Penumbra Inc. (PEN) CEO Adam Elsesser on Q2 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Equipment

Shares Out. (M)

34.38

Shares Float (M)

31.11

% Held by Insiders

9.50

% Held by Institutions

75.70

Shares Short (K)

2105

Shares Short Prior Month (K)

Stock Financials

EPS

0.320

EPS Est. Current Year

-0.210

EPS Est. Next Year

0.100

EPS Est. Next Quarter

-0.020

Forward EPS

0.440

Book Value (p.s.)

10.050

PEG Ratio

20.78

Profit Margin

7.19

Operating Margin

4.58

Return on Assets (ttm)

6.2

Return on Equity (ttm)

7.1

Qtrly Rev. Growth

36.0

Gross Profit (p.s.)

1.593

Sales Per Share

EBITDA (p.s.)

0.054

Qtrly Earnings Growth

Operating Cash Flow (M)

20.68

Levered Free Cash Flow (M)

-7.78

Valuation

P/E

400.94

P/E Growth Ratio

0.04

P/BV

12.77

P/S

378275232.00

P/CF

213.29

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-11-16

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.